VivoSim Labs, Inc. (VIVS) Stock Analysis

VivoSim Labs, Inc. (VIVS) is a publicly traded company in the HEALTHCARE sector. It trades at $1.29, carries a market capitalization of $3.73M, a price-to-earnings ratio of 0.73. This page summarizes the public market data, fundamentals, and frequently asked questions for VIVS, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $1.29
• Market Cap: $3.73M
• P/E Ratio: 0.73
• EPS: $1.76
• 52-Week High: $5.30
• 52-Week Low: $1.22

Market Sentiment

VivoSim Labs, Inc. currently has a Bullish sentiment score of 0.28.

About VivoSim Labs, Inc.

VivoSim Labs, Inc. is a pioneering biotechnology firm based in San Diego, California, dedicated to revolutionizing disease modeling through the development of advanced 3D tissue technologies. By creating biomimetic tissues that accurately reflect the complexities of human diseases, the company aims to enhance drug discovery, disease understanding, and therapeutic approaches. With a commitment to innovation, VivoSim is positioned to play a critical role in the future of personalized medicine a...

GNG Research Analysis

GNG Research scores VivoSim Labs, Inc. (VIVS) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for VIVS.

Frequently Asked Questions

Does VIVS pay dividends?

VivoSim Labs, Inc. (VIVS) does not currently pay a regular dividend.

What is VIVS's P/E ratio?

VivoSim Labs, Inc. has a price-to-earnings (P/E) ratio of 0.73.

What is VIVS's market cap?

VivoSim Labs, Inc. (VIVS) has a market capitalization of $3.73M with a current stock price of $1.29.